在住院精神病治疗中治疗失眠:临床实践评估
C L Schneider1, M Anselin2, E Hertenstein1
1Department of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
European archives of psychiatry and clinical neuroscience
|February 18, 2026
概括
失眠的认知行为疗法 (CBT-I) 在精神病医院治疗中未得到充分利用,许多专业人员缺乏知识,面临实施挑战. 在这些环境中,催眠药仍然是对失眠的常见治疗方法.
科学领域:
- 精神病学是一个精神病学.
- 睡眠医学 睡眠医学
- 心理健康研究 心理健康研究
背景情况:
- 失眠严重影响全球生活质量,精神疾病患者中普遍存在.
- 失眠的认知行为疗法 (CBT-I) 是推的第一线治疗方法,即使是那些患有并发症的人.
- 关于在住院精神病诊所管理失眠的数据有限.
研究的目的:
- 评估目前在住院精神病治疗中的失眠管理实践.
- 评估心理健康专业人员对CBT-I的知识和实施情况.
- 分析精神病医院住院患者的夜间药物使用情况.
主要方法:
- 对80名精神卫生专业人员进行了一项关于失眠治疗的调查.
- 从245个住院精神病患者的精神病学记录中提取了夜间药物使用数据.
- 用两种互补的方法来检查临床实践.
主要成果:
- 95%的专业人员遇到患有失眠的患者;然而,只有56%正确地将CBT-I确定为一线治疗.
- 很少提供CBT-I (65%的受访者),其中的障碍包括缺乏知识,患者的期望和时间限制.
- 药物治疗是常见的,40%的患者使用二类药物,其他催眠药也经常被处方.
结论:
- 失眠是住院精神病治疗中普遍存在的问题,基于证据的CBT-I的实施不足.
- 目前的治疗通常依赖于催眠药,突出了指导方针和实践之间的差距.
- 进一步研究和适应CBT-I对于改善这一群体的睡眠和健康结果至关重要.
相关概念视频
Management of Insomnia
690
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
690
Insomnia
508
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
508
CNS Depressants: Barbiturates and Benzodiazepines
1.5K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.5K
Sedatives and Hypnotics Drugs: Miscellaneous Agents
636
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
636
Substance Use Disorders Affecting Sleep
463
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
463
Psychosis: Goals of Pharmacotherapy
555
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
555


